Benzinga - Tue, 02 Mar 2021 17:21:21 -0400
Benzinga - Tue, 16 Feb 2021 17:08:00 -0400
Benzinga - Thu, 21 Jan 2021 06:03:57 -0400
Benzinga - Wed, 23 Dec 2020 06:03:40 -0400
Benzinga - Tue, 22 Dec 2020 13:43:32 -0400
Benzinga - Mon, 21 Dec 2020 06:05:32 -0400
Benzinga - Tue, 15 Dec 2020 05:58:41 -0400
Benzinga - Mon, 14 Dec 2020 13:02:42 -0400
Benzinga - Mon, 07 Dec 2020 11:06:49 -0400
load more
Sector: Health Care.Industry: Biotechnology
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-14
REV
Q4 2020Est.ActualSurprise
EPS-0.540-0.510 0.0300
REV3.940M6.689M2.749M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
NRIXNurix Therapeutics12.43%1.4B

Nurix Therapeutics Company Questions & Answers

Q

How do I buy Nurix Therapeutics (NRIX) stock?

A

You can purchase shares of Nurix Therapeutics (NASDAQ: NRIX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Nurix Therapeutics's (NRIX) main competitors?

A
Q

What is the target price for Nurix Therapeutics?

A

The latest price target for Nurix Therapeutics (NASDAQ: NRIX) was reported by JP Morgan on 2021-01-29. The analyst firm set a price target for 56.00 expecting NRIX to rise to within 12 months (a possible 53.30% upside). 7 analyst firms have reported ratings in the last year.

Q

How much is Nurix Therapeutics (NRIX) stock ?

A

The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $36.53 last updated Fri Mar 05 2021 21:00:01 GMT+0000 (Coordinated Universal Time).

Q

When is the next Nurix Therapeutics (NRIX) dividend?

A

There are no upcoming dividends for Nurix Therapeutics.

Q

When is Nurix Therapeutics (NASDAQ:NRIX) reporting earnings?

A
Nurix Therapeutics’s Q1 earnings are confirmed from now on May 14, 2021.
Q

When is the upcoming split for NRIX?

A

There is no upcoming split for Nurix Therapeutics.